NORCET 7 Prelims -2024
Obstetrics & Gynaecology
Easy

A nurse is administering carboprost to a patient with postpartum hemorrhage (PPH). What is the primary action of carboprost in managing PPH?

Appeared in: NORCET 7 Prelims -2024

Explanation

  • Carboprost is a synthetic prostaglandin (15-methyl PGF2α) that functions as a potent uterotonic agent.
  • Its primary mechanism of action is to stimulate strong, sustained contractions of the myometrium (uterine muscle).
  • These contractions mechanically compress the bleeding blood vessels at the placental implantation site, which is the primary method for controlling postpartum hemorrhage caused by uterine atony.

Why Other Options Were Wrong

  • Option B: Carboprost does not reduce blood pressure. In fact, a common and significant adverse effect is hypertension (high blood pressure).
  • Option C: This describes the goal of fluid and blood product resuscitation, not the action of a uterotonic drug. Carboprost stops ongoing hemorrhage but does not replace lost volume or reverse hypovolemia.
  • Option D: Carboprost's mechanism is mechanical compression via uterine contraction, not a pharmacological effect on the coagulation cascade. It is not an anticoagulant or a pro-coagulant.

Related Visual

Visual explanation — Related Visual
  • Visual 1: Diagram - Illustrating the mechanism of postpartum hemorrhage from uterine atony, showing dilated spiral arteries in a flaccid uterus versus compressed arteries in a contracted uterus. This helps visualize why stimulating contractions is effective.
  • Visual 2: Table - Comparing the primary uterotonic agents (Oxytocin, Methylergonovine, Carboprost, Misoprostol), their class, mechanism, and key contraindications, providing a quick reference for clinical decision-making.
Clinical Relevance
  • Nursing practice connection: Use the key finding related to Pharmacology of Uterotonic Agents for Postpartum Hemorrhage to guide bedside assessment, documentation, and the next nursing action.
  • Carboprost is a critical second-line medication for PPH when first-line agents like oxytocin fail. Nurses must be prepared to administer it promptly under medical direction.
  • A crucial nursing responsibility is to perform a rapid assessment for contraindications, especially a history of asthma, as carboprost can induce severe, life-threatening bronchospasm.
  • Post-administration monitoring is vital. The nurse must closely watch for adverse effects such as hypertension, fever, vomiting, and severe diarrhea, and manage them accordingly.
How to Approach the Question
  • This is a pharmacology-based factual recall question.
  • First, identify the drug mentioned in the stem: Carboprost.
  • Recall the drug class and its primary use. Carboprost (Hemabate) is a prostaglandin used in obstetrics to manage postpartum hemorrhage.
  • Remember the primary mechanism of action for uterotonic agents in PPH: they cause the uterus to contract forcefully.
  • Evaluate the options based on this primary action. Option A, 'Stimulating uterine contractions to reduce bleeding,' directly aligns with the known mechanism of uterotonic drugs.
  • Systematically eliminate the other options. Recall that a major side effect of carboprost is hypertension, which makes option B incorrect. Differentiate between treating the cause of bleeding (contraction) and treating the effects of blood loss (volume replacement), making option C incorrect. Recognize that the mechanism is muscular contraction, not alteration of blood clotting, making option D incorrect.
Concept Tested & Keywords
  • Concept Tested: Pharmacology of Uterotonic Agents for Postpartum Hemorrhage
  • Stem keywords: carboprost, postpartum hemorrhage, PPH, primary action
  • Lead-in keywords: primary action
  • Clinical cues: Age/sex group narrows the expected diagnosis, intervention, or normal reference range.
  • Negative lead-in flag: false

Question ID

QOZwiO1A4mSZ96PX4eMrKH

Practise the full NORCET 7 Prelims -2024

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Pharmacotherapeutics in Obstetrics Questions

More NORCET 7 Prelims -2024 Questions